Stone Pharmaceuticals Group: Net profit is expected to be approximately HK$471 million in 2025, a decrease of 55.6% year-on-year.

Shi Si Yao Group announced that in 2025, the total sales revenue is expected to be approximately 3.812 billion RMB, a decrease of 27.6% compared to the previous year; in Hong Kong dollars, the total sales revenue for the year is expected to be approximately 4.165 billion HKD, a decrease of 27.8% compared to the previous year. During the same period, the gross profit margin is expected to be around 41.6%, a decrease of 8.8 percentage points compared to the previous year. The net profit is expected to be around 471 million HKD, a decrease of 55.6% compared to the previous year.